Advertisement
"The FDA's written response that it has reviewed the submitted safetyevidence and has no questions about the GRAS determination for D-ribose is thegovernment's highest recognition of a food ingredient for safety and purity,"said Raj Khankari, Ph.D., CEO of Bioenergy, Inc. The company has held"self-affirmed" GRAS status for years. "Today, we are gratified that the FDAhas officially validated our assessment."
Advertisement
"The FDA's 'no questions letter' signals to the major food and beveragemanufacturers that we have invested all the resources possible to guaranteethe quality and safety of our D-ribose products for the benefit of customersand consumers."
Bioenergy has amassed a large body of scientific literature regarding usesof ribose for people across all age and health categories. The company hasmore than 40,000 customers for its proprietary Corvalen products alone, andmillions worldwide use Bioenergy ribose in other products. It is commonlyfound in functional foods like energy bars (Detour, FastFuel, Marathon) andbeverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water).Currently, Bioenergy D-ribose is included as an ingredient in approximately100 products.
In larger quantities as a Medical Food, D-Ribose also has been shown toassist patients with compromised heart function and is also widely used bypatients with Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS).
Bioenergy, Inc. (http://www.bioenergy.com) is a privately held,Minneapolis-based life sciences company whose core technology lies in thedevelopment and commercialization of products based on the physiologicalbenefits of D-ribose for health and wellness. In addition to a pharmaceuticalsubsidiary, Bioenergy has two other companies. Bioenergy Life Science, Inc.manufactures and sells D-ribose as an ingredient to nutraceutical firms forbeverages and foods; as a medical food through doctors and clinics; and as adietary supplement for energy recovery (reduces fatigue, muscle pain, sorenessand stiffness following exercise). Viacell, LLC is developing technologyrelated to the enhancement of blood components.
SOURCE Bioenergy, Inc.
